Shareholders to Vote on Highly Dilutive Stock Plan, Critical Warrant Exercisability, and Reverse Stock Split

summarizeSummary

Avalon GloboCare Corp. is seeking shareholder approval for a highly dilutive new stock incentive plan and the exercisability of warrants from a recent private placement, alongside a reverse stock split, all critical for its financial stability and Nasdaq listing compliance.

check_boxKey Events

• Shareholder Meeting Scheduled

  The company will hold its 2026 Annual Meeting of Stockholders on June 9, 2026, to vote on several key proposals, including director elections, auditor ratification, a new stock incentive plan, executive compensation, warrant approval, and a reverse stock split.

• Highly Dilutive Stock Incentive Plan Proposed

  Shareholders are asked to approve a new 2026 Stock Incentive Plan with an initial reserve of 2,000,000 shares and an 'evergreen' provision for annual increases of 5% of outstanding shares. The initial share reserve alone represents a potential dilution of over 27% of the current market capitalization.

• Critical Warrant Exercisability Approval Sought

  The company is seeking approval for the exercisability of Series A-1, Series A-2, and Placement Agent Warrants issued in a private placement that closed on February 27, 2026. These warrants, if fully exercised, could result in the issuance of 13,063,728 additional shares and generate up to $6.69 million in proceeds. Failure to approve would lead to substantial costs and prevent the company from receiving these potential funds.

• Reverse Stock Split Re-Proposed

  The Board is recommending approval for authority to effect a reverse stock split at a ratio between 1-for-2 and 1-for-25. This proposal aims to increase the per-share bid price to maintain compliance with Nasdaq's minimum bid price rule, following a prior approval on April 1, 2026.

auto_awesomeAnalysis

This preliminary proxy statement outlines critical proposals for Avalon GloboCare Corp.'s upcoming annual meeting, revealing significant potential dilution and ongoing financial challenges for the micro-cap company. The proposed new stock incentive plan, combined with the approval for exercisability of warrants from a recent private placement, represents an exceptionally high potential dilution of over 180% of current outstanding shares. While the warrant approval is crucial for the company to potentially secure $6.69 million in proceeds and avoid substantial penalties, it comes at a severe cost to existing shareholders. The re-proposal of a reverse stock split further highlights the company's persistent struggle to maintain Nasdaq listing requirements, following a substantial net loss reported just days prior. Investors should be aware of the significant dilutive impact and the company's precarious financial position.